Weil, Gotshal & Manges LLP has advised Kainos Capital. FINN DIXON & HERLING has represented Super-Sod, Heartwood Partners and its investors. Kainos Capital has completed the...
Kainos Capital Acquires Super-Sod from Heartwood Partners
Veris Residential to Be Acquired by Investor Consortium Led by Affinius Capital and Vista Hill Partners for $3.4 Billion
Weil Gotshal & Manges and Seyfarth Shaw have advised Veris Residential, Inc. Skadden, Arps, Slate, Meagher & Flom, Greenberg Traurig, and Simpson Thacher & Bartlett have...
Xplor Technologies and Clubessential Holdings Announce Strategic Merger
Weil has advised Advent International and its portfolio company Xplor Technologies. Cooley has advised Clubessential Holdings. Xplor Technologies, a global platform specializing in software and embedded...
GHK Capital Partners Acquires Rogers Building Solutions
Weil, Gotshal & Manges LLP has advised GHK Capital Partners LP. Neal, Gerber & Eisenberg LLP has advised Rogers Building Solutions. GHK Capital Partners LP has...
Sale of Clarity Software Solutions to mPulse
Dechert has advised Morgan Stanley Capital Partners and Clarity Software Solutions. Weil advised PSG and its portfolio company mPulse. Morgan Stanley Capital Partners announced the completion...
PSG Completes $125 Million Strategic Growth Investment in HeroDevs
Weil, Gotshal & Manges has advised PSG Equity L.L.C.; Foley & Lardner has advised HeroDevs, Inc. PSG Equity L.L.C. has made a strategic growth equity investment...
L’Oréal to Acquire Color Wow, Expanding Professional Haircare Portfolio
Weil has advised L’Oréal. L’Oréal has entered into an agreement to acquire Color Wow, a prominent and rapidly growing professional haircare brand. The transaction is set...
GMS to be Acquired by The Home Depot’s SRS Distribution for $5.5 Billion
Alston & Bird has advised GMS. Weil has represented The Home Depot. The Home Depot, through its specialty trade distribution subsidiary SRS Distribution Inc., has entered...
Sanofi Acquires Blueprint Medicines in $9.5 Billion Deal
Weil has advised Sanofi on the deal. Sanofi has announced the acquisition of Blueprint Medicines, a globally recognized, publicly traded biopharmaceutical company. The transaction is valued...